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Cardiovascular malformations are one of the most common
congenital birth defects observed in humans. Defects in cardiac
valves disrupt normal blood ﬂow. Zebraﬁsh are an outstanding
experimental model for studying the effects that environmental
contaminants have on developmental processes. Previous re-
search has shown that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
causes blood regurgitation in the heart and reduces peripheral
blood ﬂow in embryonic zebraﬁsh, suggesting some form of valve
failure. To test this we used video microscopy to examine valve
function and structure in developing zebraﬁsh exposed to TCDD.
TCDD exposure produced blood regurgitation at both the atrio-
ventricular (AV) and bulboventricular (BV) junctions. In marked
contrast to control embryos exposed to the vehicle dimethyl
sulfoxide, embryos exposed to TCDD failed to form valve leaﬂets
as the heart matured. In addition, whereas TCDD did not block
initial formation of the bulbus arteriosus, we found that TCDD
exposure prevented the normal growth and development of this
portion of the outﬂow tract. TCDD altered the localization of
endothelial cells at the AV and BV junctions and altered the
localized expression of mRNAs bmp4 and notch1b normally
associated with the nascent valves. Taken together, our results
demonstrate that although TCDD does not prevent the initial
speciﬁcation of the presumptive valve locations, TCDD exposure
produces severe alterations in valve development, leading to blood
regurgitation and failing circulation in the developing zebraﬁsh.
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The cardiac valves play a critical role in heart function by
preventing retrograde blood ﬂow, thereby maintaining vascular
hemodynamics. It is estimated that 25–30% of all cases of
human cardiovascular malformation involve defects in cardiac
valves (Armstrong and Bischoff, 2004). Atrioventricular (AV)
canal defects are seen in approximately 5% of congenital heart
disease, establishing this as the fourth most common congenital
heart malformation (Emmanouilides et al., 1998). Valve defects
are also observed in 16% of Down and Noonan syndrome
patients as well as infants born to gestational diabetic mothers
(Enciso et al., 2003; Stainier et al., 2002). The American Heart
Association estimates 95,000 in patient valve procedures were
performed in the United Stated alone in 2003, and about
300,000 worldwide (Thom et al., 2006; Vesely, 2005).
In humans, valve malformations include valvular stenosis
where there is a narrowing of the valve opening and valvular
insufﬁciency in which the valves do not close completely,
allowing blood regurgitation (Flanagan and Pandit, 2003).
Epidemiological studies suggest that people living in areas of
water contaminated with halogenated hydrocarbons have an
elevated risk for valvular stenosis and other cardiac malforma-
tions (Goldberg et al., 1990). Another study identiﬁed a region
of Baltimore, MD, where an increased frequency of hypoplas-
tic left heart syndrome correlated with the industrial release of
solvents, dioxins and polychlorinated biphenyls (Kuehl and
Loffredo, 2006). Understanding how genetic predisposition
and environmental factors play a role in the development and
functioning of the cardiac valves is a critical step in preventing
these diseases.
Environmentalcontaminantssuchas2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) are bioaccumulative, lipophilic halogenated
aromatic hydrocarbons that persist in the environment and
cause cardiovascular malformations in mammalian, avian
and aquatic species (Heid et al., 2001; Henry et al., 1997;
Thackaberry et al., 2005b). Fetuses from pregnant mice
exposed to TCDD exhibit a reduced heart to body weight,
reduced fetal cardiocyte proliferation, and altered expression
of cardiac genes involved in extracellular matrix (ECM)
deposition, remodeling and cardiac homeostasis (Thackaberry
et al., 2005a, b). In chickens, TCDD causes an increase in
apoptosis in cells of the outﬂow tract and the AV canal
endocardial cushions (ECs), whereas decreasing cardiomyo-
cyte proliferation (Ivnitski et al., 2001). TCDD also reduced
the growth of cells in cardiac ventricle explants isolated from
embryonic chickens (Ivnitski-Steele and Walker, 2003).
Embryonic zebraﬁsh exposed to TCDD exhibit a reduction
in common cardinal vein area and reduced number of
cardiomyocytes by 48 hpf (hours postfertilization). This is
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cardial edema, impaired looping, reduced cardiac output,
anemia, ventricular standstill, and ultimately death (Antkiewicz
et al., 2005; Belair et al., 2001; Bello et al., 2004).
The developing zebraﬁsh heart begins to beat at around 22
hpf and circulation is initiated shortly thereafter (Stainier et al.,
1993). By 48 hpf, constrictions have clearly partitioned the
heart into the sinus venosus, atrium, ventricle, and bulbous
arteriosus (Hu et al., 2000). The heart consists of an outer
myocardial layer that is contractile and an inner endocardial
layer that is continuous with the vascular endothelium. In
between these two layers lies the ECM or cardiac jelly (Yelon,
2001). The valves are formed from the endocardial cells at
three sites: the sinus venosus valve at the junction between the
sinus venosus and the atrium; the AV valve at the junction
between the atrium and the ventricle; and the bulboventricular
(BV) valve between the ventricle and the bulbus arteriosus
(BA) of the outﬂow tract (Hu et al., 2000).
Two components of the Wnt signaling pathway, bone
morphogenetic protein 4 (bmp4) and notch1b, are initially
expressed throughout the heart, but become restricted to
myocardial and endocardial cells marking the constrictions at
the presumptive valve sites by 37 and 45 hpf, respectively
(Walsh and Stainier, 2001).
There is some disagreement between reports describing the
processes involved in early valve formation. For several years
it has been thought that a subset of the AV endocardial cells
differentiate in response to myocardial cell signals, and undergo
an epithelial to mesenchymal transformation (EMT) at the site
of the nascent valve. In this process, the endothelial cells
delaminate and migrate into the cardiac jelly by 60–72 hpf. The
delaminated cells form transient structures called ECs that help
to prevent reverse blood ﬂow (Walsh and Stainier, 2001). The
ECs undergo further remodeling to form the actual valve
leaﬂets at the AV boundary. Many aspects of this process have
been observed directly and recently reported (Bartman et al.,
2004; Beis et al., 2005; Hu et al., 2000; Hurlstone et al., 2003;
Stainier et al., 2002; Wang et al., 2006)
However, a very recent report from Scherz et al. (2008) has
called this model into question. In this paper, the authors
described the use of selective plane illumination microscopy to
gather evidence that valve leaﬂets are formed directly through
an invagination process rather than through the intermediate
step of forming cushions.
Blood ﬂow and proper myocardial contractility are both
believed to play a role in valve development in zebraﬁsh.
Reducing blood ﬂow across the AV junction by obstructing the
sinus venosus results in the absence of the AV valve and the
BA (Hove et al., 2003). However, in other experiments, Bartman
et al. (2004) found that it was possible to pharmacologically
block blood ﬂow entirely, without preventing the initial steps
of valve formation.
The anecdotal report that TCDD causes blood regurgitation
in the developing zebraﬁsh heart provides a possible explana-
tion for at least part of the circulation failure that TCDD
produces in developing zebraﬁsh (Antkiewicz et al., 2005). If
TCDD altered the morphology or function of valve structures
in the heart, then blood would be expected to leak backwards
during systole, reducing cardiac output and blood ﬂow. Here
we report experiments designed to test this possibility. We used
video microscopy to demonstrate that TCDD causes both ret-
rograde blood ﬂow and valve failure. We found that an initial
failure of the nascent valve to form a seal was followed by
a failure to form ECs or AV valve leaﬂets. Although markers of
AV junction speciﬁcation appeared normal in vehicle and
TCDD-treated embryos at 48 hpf, the clusters of endothelial
cells at the AV and BV junctions became progressively
delocalized in the TCDD-exposed embryos at later time points.
This coincided with a loss of localization and a general increase
in expression of the valve speciﬁc markers bmp4 and notch1b
in the region of the AV junction. These results demonstrate that
TCDD exposure severely disrupts heart valve formation in the
developing zebraﬁsh, a response that would be expected to
contribute to the subsequent lethality.
MATERIALS AND METHODS
Zebraﬁsh lines. All zebraﬁsh embryos were kept at 28.5 in egg water (60
lg/ml Instant Ocean Salts; Aquarium Systems, Mentor, OH) with a 14-h/10-h
light/dark cycle. Wild-type AB embryos were used in assessing blood
regurgitation and for in situ hybridization experiments. Embryos from the
vascular endothelial speciﬁc Tg(ﬂk1:GFP) ﬁsh (kindly provided by Dr Beth
Roman and Dr Jau-Nian Chen; Cross et al., 2003) were used for assessing the
endothelial cell localization and for assessing AV valve leaﬂet development.
Tg(cmlc2:gfp) embryos a kind gift from Dr C. Geoffrey Burns (Rottbauer et al.,
2006) were used to assess the development of the BA.
TCDD exposure. TCDD of > 99% purity was obtained from Chemsyn
(Lenexa, KS) and dissolved in 0.1% dimethyl sulfoxide (DMSO). Embryos
were placed in glass vials containing egg water and exposed to either TCDD
(1 ng/ml) or 0.1% DMSO (vehicle) for 1 h on a rocker. After the 1-h exposure,
the embryos were rinsed with fresh egg water and transferred to Petri dishes and
raised at 28.5 in a 14-h light/10-h dark cycle. The maximum number of eggs/ml
of egg water did not exceed 10 embryos. For our experiments, each group of
embryos exposed in a single vial constitutes an n ¼ 1.
Assessing blood regurgitation and endothelial cell localization. Live
embryos were mounted on a slide containing 3% methylcellulose to reduce
movement and blood regurgitation across the valves was assessed by following
video recordings made with a Nikon TE300 inverted microscope with a high-
speed Motion Scope camera. Statistical signiﬁcance of blood regurgitation
incidence at the AV junction was determined via Fisher’s p-test. For endothelial
cell localization, Tg(ﬂk1:GFP) embryos were dosed and collected as above but
visualized using a Princeton instruments Micromax charge coupled device
camera and MetaMorph imaging software (Molecular Devices, CA).
Assessing development of the BA chamber. Tg(cmlc2::gfp) embryos were
exposed to TCDD or vehicle as described above. In this strain, gfp is seen in the
atrium and ventricle, but is absent in the BA. At 24 hpf embryos were
transferred to ﬁsh water containing 0.003% 1-phenyl-2-thiourea (PTU) to
prevent pigment formation. At 36 hpf live embryos were transferred to ﬁsh
water containing 10lM diaminorhodamine-4M AM (DAR-4M AM)
(Calbiochem, San Diego, CA) in ﬁsh water adjusted to pH 7.0 and kept overnight
in the dark for detection of the bulbus (Grimes et al. 2006). DAR-4M AM is an
in vivo cell permeable, photo-stable nitric oxide reactive dye that marks the
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h, and the presence of the bulbus was assessed at 48, 60, 72, 76, 96, and 120
hpf using a Nikon TE300 inverted microscope connected to a Princeton
instruments Micromax CCD camera.
Immunohistochemistry. Tg(ﬂk1:GFP) embryos were exposed to TCDD
or vehicle as described above. At 24 hpf embryos were transferred to ﬁsh water
containing 0.003% PTU to prevent pigment formation. At 120 hpf they were
euthanized in 1.67 mg/ml Tricaine (MS 222, Sigma, St Louis, MO), rinsed in
phosphate-buffered saline (PBS, Cellgro), and ﬁxed overnight in 4%
Paraformaldehyde in PBS. Whole embryos were then mounted on a glass
slide and observed with a Nikon C1 laser scanning confocal microscope.
In situ hybridization. Vehicle and TCDD-treated AB embryos were
collected at 48, 60, and 72 hpf. The embryos were euthanized in 1.67 mg/ml
Tricaine (MS 222, Sigma), rinsed in PBS and ﬁxed overnight in 4%
Paraformaldehyde in PBS. The next day they were washed in PBS, and
bleached in a mix of 3% Hydrogen peroxide and 1% potassium hydroxide.
They were then washed in PBS, and dehydrated in methanol and stored at
 20C until needed. TCDD-treated ﬁsh were tail clipped for identiﬁcation after
dehydration so that both treatment groups could be processed together for the in
situ hybridization steps. This ensured identical staining. BMP4 and Notch1b
plasmids were kindly provided by Dr Randall Peterson. Riboprobes were
labeled with digoxigenin-UTP and visualized using anti-digoxigenin-AP Fab
fragments (Roche Applied Science, Indianapolis, IN) with 4-nitro blue
tetrazolium chloride solution and 5-bromo-4-chloro-3-indolyl-phosphate as
substrates. Hybridization was carried out at 65C. Overall for the 60 hpf samples
n ¼ 16 from two separate experiments; for the 48 and 72 hpf samples n ¼ 26
from three separate experiments. A single representative embryo was selected for
each treatment group at each time point and photographed with an Optronics
MicroFire camera (Leica) mounted onto a Leica MZ16 stereomicroscope (Leica).
RESULTS
TCDD Exposure Causes Blood Regurgitation at the AV Valve
Anecdotal evidence suggested that a part of the reduction in
blood ﬂow produced by TCDD might be due to regurgitation
of blood at the sites of the nascent valves in the developing
heart. We used video microscopy to examine the incidence of
blood regurgitation in TCDD-exposed embryos and in control
embryos exposed to DMSO from 48 to 120 hpf. We found
evidence that TCDD produced an overall greater incidence
of blood regurgitation at the AV boundary compared with
vehicle (Fig. 1).
We saw signiﬁcant blood regurgitation at the AV boundary
beginning at approximately 60 hpf in the TCDD-exposed
embryos, but not in the controls. This became progressively
more severe as development progressed. By 72 hpf, TCDD-
exposed embryos demonstrate clear signs of valvular insufﬁ-
ciency. We observed that the ring of tissue at the presumptive
AV valve site failed to shut completely during ventricular
systole. This left a small opening that allowed blood cells to
trickle back into the atrium in TCDD-exposed ﬁsh examined at
72 hpf (Fig. 2) (Supplemental Movie: 72hpfAB.mov). As the
atrium contracted, blood was expelled from the atrium into the
ventricle; however, as the ventricle contracted a small fraction
of cells could be seen pushed in a retrograde motion from
within the ventricle back into the atrium. By 96 hpf virtually all
of the blood moving into the ventricle was then moved back-
wards into the atrium during systole, virtually abolishing blood
ﬂow (Supplementary Data, supplemental movie: 96hpfAB.mov).
TCDD Exposure Prevents Formation of Valve Cushions and
Leaﬂets at the AV Junction
We used Tg(ﬂk1:GFP) to determine whether TCDD
prevents the distinct thickening of endothelial cells at the AV
junction that has been reported to be indicative of cardiac
cushion formation (Bartman et al., 2004; Stainier et al., 2002).
Figure 3 shows successive images from high-speed video
recordings in which the endothelial cells are marked with GFP
ﬂuorescence. In the control zebraﬁsh, endothelial cells were
observed in distinct clusters that appeared to form actual valve
leaﬂets as early as 72 hpf, consistent with the results recently
reported by Scherz et al. (2008). These leaﬂets were even more
distinct and well developed by 96 hpf. This can be even more
readily discerned in movies included as supplemental data
(supplemental movies: 72hpf_ﬂk.mov; 96hpf_ﬂk.mov). In strik-
ing contrast, there was no evidence of either cushion or leaﬂet
formation in the TCDD-exposed zebraﬁsh at either 72 or 96
FIG. 1. TCDD causes blood regurgitation in the developing zebraﬁsh
heart. Newly fertilized zebraﬁsh eggs were treated with TCDD or DMSO
as a vehicle control as described in the ‘‘Materials and Methods.’’
Videomicrographs were recorded at the indicated times during development
and individuals were scored for retrograde blood ﬂow across the AV junction.
Asterisks indicate a statistical difference between TCDD and control hearts p  
(0.05) determined via one-tailed Fisher’s p-test. Error bars indicate standard
error.
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hearts were clustered tightly so as to form a mass that deci-
sively occludes the lumen during contraction, the endothelial
cells in the TCDD-treated hearts were less concentrated, leav-
ing what appears to be a small gap during contraction. By
96 hpf there was no readily discernible cluster of endothelial
cells at the AV junction in the TCDD-treated hearts.
TCDD produced similar effects at the BV junction, in which
the control hearts had distinct clusters of endocardial structures
forming discernible ﬂaps by 96 hpf, whereas the TCDD-treated
hearts had a more diffuse and unorganized arrangement of
endothelial cells. These results are consistent with the results
shown in Figures 1 and 2, demonstrating that TCDD prevents
sealing at the AV junction, allowing retrograde blood ﬂow.
We used confocal microscopy to get a better view of leaﬂet
formation at the AV junction at 120 hpf in treated and vehicle
Tg(ﬂk1:GFP) embryos (Fig. 4). Because it was possible that
TCDD had simply delayed leaﬂet formation, we chose a time
point two days after we had ﬁrst seen signs of leaﬂet formation
in the control hearts. If TCDD were simply delaying the
emergence of leaﬂets, one might expect to see evidence of
leaﬂet formation in the TCDD-exposed hearts by this time
point. At 120 hpf, the nascent valve leaﬂets were clearly visible
at the AV boundary in the control hearts. We saw no signs of
leaﬂets in the TCDD-exposed hearts; aggregation of endothe-
lial cells at the AV boundary was greatly reduced in TCDD-
treated ﬁsh.
TCDD Exposure Inhibits BA Development
During our confocal microscopy experiments, we began to
notice that TCDD produces changes in the BV valve as well as
the BA chamber itself. The BA serves as a capacitor as the
smooth muscle expands and relaxes (supplemental movie:-
dar4_120hpf.mov), protecting the gills and providing uniform
blood ﬂow (Grimes et al., 2006; Hu et al., 2000). The BA is
ﬁrst noticeable at the outﬂow side of the ventricle at around
48 hpf, when it can be observed by in vivo staining with DAR-
4M AM, a membrane permeable compound that detects nitric
oxide (Grimes et al., 2006).
We used DAR-4M AM to determine what effects TCDD has
on the formation of the BA (Fig. 5). In our hands, we could not
clearly detect the BA prior to 76 hpf. By this time, TCDD-
exposed embryos already exhibited a dramatically smaller BA
then was observed in the vehicle exposed ﬁsh. Although the
BA in vehicle treated ﬁsh steadily increased in size as seen at
the 96 and 120 hpf points, the BA in the TCDD-exposed
embryos exhibited little if any growth. This indicates that
although TCDD did not block the initial formation of a group
of DAR-4M AM staining cells at the location of the BA, it
prevented any further growth of the outﬂow chamber.
TCDD Exposure Alters Endothelial Cell Localization at the
AV Junction
Among the early steps of valve formation is the accumu-
lation and clustering of endothelial cells lining the heart at the
AV and BV junctions. Using Tg(ﬂk1:GFP) we followed the migra-
tion and accumulation of endothelial cells at the AV boundary
over time. We were able to clearly distinguish a cluster of
endothelial cells at the AV and BV junction by 36 hpf
demarcating the junction between the atrium and ventricle and
between the ventricle and outﬂow tract (data not shown). This
group of GFP-positive cells was even more distinct in lateral
view images at 48 hpf, where both vehicle and TCDD-treated
ﬁsh showed a distinct cluster of endothelial cells at the AV
junction, and a distinct cluster of endothelial cells at the BV
junction (Fig. 6). We were unable to detect any difference
between the localization of endothelial cells at the AV or BV
FIG. 2. TCDD prevents closure of the nascent AV valve during systole.
Newly fertilized zebraﬁsh eggs were treated with TCDD or DMSO as a vehicle
control as described in the ‘‘Materials and Methods.’’ Representative lateral
view micrographs are shown for hearts at the indicated time in development.
The arrows indicate an open passage between the atrium and ventricle. Open:
the image was taken during diastole in which the AV junction is relaxed.
Closed: the image was taken during systole, during which the AV junction has
contracted to its fullest extent. An open passage between the ventricle and
atrium was consistently observed associated with retrograde blood movement at
72 hpf (see supplemental movie: 72hpfAB.mov).
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However, after 48 hpf we observed progressive loss of
localization of these GFP-positive endothelial cells in the
TCDD-treated samples. This TCDD-induced delocalization of
endothelial cells at the AV junction was clearly evident in the
ventral view images taken at 72 hpf and 96 hpf (Figs. 3 and 6).
We also found that TCDD caused the GFP-positive
endothelial cells at the BV junction to become progressively
less restricted at the BV junction over time. At 72 hpf, vehicle
exposed embryos clearly exhibited a distinct cluster of endo-
thelial cells at the BV junction. However, in TCDD-exposed
ﬁsh the endothelial cells at the BV junction were distributed
across a larger region of the outﬂow tract compared with the
vehicle control (Fig. 6) (supplemental movie: 72hpf_ﬂk).
TCDD Alters AV Boundary Speciﬁcation during the EMT
Process
During early heart development genes encoding bone
morphogenetic protein 4 (bmp4) and notch1b are expressed
throughout the heart. However, as the heart develops, these
markers become restricted to the presumptive AV valve region:
bmp4 is expressed in the myocardial layer, and notch1b is
found in the endocardial layer (Walsh and Stainier, 2001). We
FIG. 3. TCDD alters the arrangement of endothelial cell clusters at valve sites. Newly fertilized Tg(ﬂk1:GFP) eggs were treated with TCDD or DMSO as
a vehicle control as described in the ‘‘Materials and Methods.’’ The ﬁgure shows sequential frames taken at six images per second. Representative ventral view
ﬂuorescence micrographs showing endocardial cells at the AV and BV junctions are shown for 72 and 96 hpf as indicated. A indicates atrium; V indicates
ventricle. Arrows show the location of the AV and BV junctions. The arrows are positioned to indicate forming valve leaﬂets at the junctions in the DMSO images;
leaﬂets were not observed in the TCDD-exposed hearts.
FIG. 4. Valve leaﬂets fail to form in 120 hpf zebraﬁsh exposed to TCDD.
Newly fertilized Tg(ﬂk1:GFP) eggs were treated with TCDD or DMSO as
a vehicle control and ventral view confocal micrographs were recorded at 120
hpf as described in the Materials and Methods. Representative images show the
AV junction, indicated by the arrow. Valve leaﬂets can be clearly seen ﬂanking
the AV passage in the DMSO heart. A indicates atrium; V indicates ventricle.
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AV boundary speciﬁcation.
At 48 hpf, we consistently observed a small ring or dot of
bmp4 staining, corresponding to the previously reported
localized expression at the AV boundary myocardium in both
vehicle and TCDD-exposed embryos. This is visible as a small
region of staining at the AV boundary and another at the
outﬂow tract junction (Fig. 7). By 60 hpf, a point at which the
EMT process has normally started (Beis et al., 2005), we
consistently saw bmp4 expressed in a broader, less restricted
region in TCDD-treated embryos. By 72 hpf, the bmp4 signal
was consistently more intense in the TCDD-treated hearts than
in the controls, and covered a region that extended completely
beyond the heart, making it quite evident that expression was
no longer restricted to the AV boundary.
We observed very similar results with notch1b staining. As
with bmp4, we initially observed a distinct spot of notch1b
staining marking the AV junction endocardium in both control
and TCDD-treated ﬁsh (Fig. 8). However, in the TCDD-treated
ﬁsh this pattern of localized expression steadily broadened as
the notch signal became progressively delocalized and stronger
at 60 and 72 hpf.
These results demonstrate that TCDD alters processes
specifying valve development at the AV boundary. The timing
of the changes in bmp4 and notch1b localization corresponds to
the loss of the localized pattern of endothelial cells at the AV
and BV junctions depicted in Figure 6, and takes place at
a stage in development during which critical processes affect-
ing valve formation have been reported to occur. Thus, it is not
surprising that TCDD prevented subsequent formation of valve
structures, because TCDD leads to a loss of cellular conditions
required for valve formation.
DISCUSSION
Our results demonstrate that TCDD exposure produces
alterations in valve formation in the developing zebraﬁsh heart.
TheseeffectswereﬁrstobservedasafailureoftheAVjunctionto
completely seal as the ventricle beats, allowing blood cells to slip
backwards during ventricular systole. Although the observed
bloodregurgitationattheAVandBVvalvesisnottheonlydefect
causedbyTCDD,thefailureofafractionofthebloodcellstopass
through the valves in the proper direction must contribute to the
loss of peripheral circulation that TCDD exposure produces.
The changes in heart valve formation and function were
associated with disruption of cellular patterns associated with
FIG. 5. Development of the BA is inhibited by TCDD. Tg(cmlc2::gfp)
embryos were exposed to TCDD or DMSO vehicle and treated with DAR-4M
AM to stain the BA as described in the Materials and Methods. Embryos were
mounted in methylcellulose and visualized using epiﬂuorescence. Lateral view
images of representative vehicle and TCDD embryos are shown for 76, 96, and
120 hpf are shown. The head is toward the left of the ﬁgure, and the dorsal side
is to the top. The ventricle is labeled with GFP, and indicated by a V; the DAR-
4 signal identifying the BA is seen as red, and is indicated by an arrow.
FIG. 6. TCDD alters endothelial cell localization at the AV and BV
junctions. Newly fertilized Tg(ﬂk1:GFP) eggs were treated with TCDD or
DMSO as a vehicle control as described in the ‘‘Materials and Methods.’’
Representative ﬂuorescence micrographs showing lateral views (48 and 60 hpf)
and ventral views (72 and 96 hpf) of the heart are shown. These orientations
were selected to give the best view of the heart at each stage of development.
A indicates atrium; V indicates ventricle. Arrows show the locations of the AV
and BV junctions.
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cells that is normally observed at the AV and BV junctions as
a precursor to valve development was disrupted by TCDD.
Initially these localized clusters of endothelial cells formed
normally despite the presence of TCDD, and were clearly
present at 48 hpf. However, in the TCDD-exposed ﬁsh the
endothelial cells do not remain localized to these junctions.
This loss of endothelial cell localization coincided closely with
delocalization of bmp4 and notch1b expression.
It is interesting to note that TCDD did not simply delay or
halt the process of valve formation. At early time points the
contractile process at the AV junction was normal, producing
a functional barrier to retrograde blood ﬂow despite the
presence of TCDD. In addition, the localization of endothelial
cells and the expression of notch1b and bmp4 appeared normal
at early time points, despite the presence of TCDD. However,
as time progressed, all of these normal features of early valve
formation deteriorated, reversing whatever progress toward
valve formation that had been made. Similarly, although
TCDD did not prevent the initial formation of the BA, the size
of the BA was greatly reduced in TCDD-exposed zebraﬁsh. As
with valve formation, TCDD did not appear to block the initial
process of tissue speciﬁcation, but appeared to prevent the
development needed to complete the nascent structure.
TCDD and Endothelial Cells in the Heart
This work was initiated in part by casual observations that
TCDD alters the distinct clusters of endothelial cells labeled
with GFP at the sites of valve formation. Thereafter, we
conducted numerous experiments directed at determining
whether TCDD affects the different steps in the EMT process
described in detail by Beis et al. (2005). As we were preparing
this manuscript a report from Scherz et al. (2008) described
work suggesting that there is no EMT process in the
developing heart, and that instead the leaﬂets form directly
from layers of endothelial cells. Some of our work, notably our
observation of visible leaﬂets of GFP-positive endothelial cells
in movies of hearts as early as 72 hpf, supports this recently
proposed model. Beyond this, our work has little to contribute
to the question of whether zebraﬁsh valve formation goes
through the classical EMT. Instead, our results demonstrate
that the AHR agonist TCDD inhibits valve formation, entirely
disrupting endothelial cell positioning at the presumptive valve
site.
TCDD Alteration of bmp4 and notch1b Expression
Bmp4 and Notch1 are Wnt/b-catenin pathway components
needed for normal valve development. Zebraﬁsh mutants such
as jekyll lack localization of bmp4 and notch1b at the AV
boundary. These mutants fail to form ECs at 96 hpf and have
retrograde blood ﬂow (Stainier et al., 1996, 2002). Experiments
in mice with a hypomorphic bmp4 allele indicate that bmp4 is
speciﬁcally required for proper AV septation after the cushions
have formed (Jiao et al., 2003). Mutation in the notch
1r e c e p t o ri nm i c eo rt h eRBPJk effector results in abnormal endo-
cardial adhesion complexes and abortive endocardial EMT
in vivo and in vitro (Grego-Bessa et al., 2004). Thus, the effects
of TCDD on bmp4 and notch1b could be upstream of the
morphological defects that we observed.
However, increased bmp4 and notch1b expression has been
associated with promoting valve formation. Expression of
mouse Notch1 (N1IC) in zebraﬁsh embryos produces hyper-
cellular ECs and enlarged AV valves, whereas suppression of
N1IC causes atrophic ECs (Timmerman et al., 2004). Activa-
tion of the Wnt/b-catenin pathway leads to excessive develop-
ment of valve cushions. This is associated with an upregulation
of bmp4 and notch1b (Hurlstone et al., 2003). One might
therefore expect the increased bmp4 and notch1b expression
FIG. 7. TCDD alters bmp4 mRNA localization in the developing heart.
Newly fertilized zebraﬁsh eggs were treated with TCDD or DMSO as a vehicle
control as described in the ‘‘Materials and Methods.’’ Representative lateral
view micrographs are shown for hearts stained by in situ hybridization with
a probe speciﬁc for bmp4 mRNA. Arrows indicate bmp4 signal at the location
of the AV boundary myocardium. The head is toward the top of each panel and
the dorsal side is to the right.
FIG. 8. TCDD alters notch1b mRNA localization in the developing heart.
Newly fertilized zebraﬁsh eggs were treated with TCDD or DMSO as a vehicle
control as described in the ‘‘Materials and Methods.’’ Representative lateral
view micrographs are shown for hearts stained by in situ hybridization with
a probe speciﬁc for notch1b mRNA. Arrows indicate notch1b signal at the
location of the AV boundary endocardium. The head is toward the top of each
panel and the dorsal side is to the right.
TCDD CAUSES HEART VALVE DEFECTS IN ZEBRAFISH 309produced by TCDD would lead to increased formation of valve
structures, rather than what we observed.
It is likely though that EC formation is regulated by a more
complex signal than the simple levels of notch1b and bmp4
mRNAs. For example, zebraﬁsh cloche mutants fail to develop
endocardium and lack notch1b mRNA. This failure to express
notch1b is associated with a loss of bmp4 localization at the
AV junction. Thus, the absence of one layer abolishes pro-
cesses needed to specify the site of the AV ring (Milan et al.,
2006). It is possible that the elevated bmp4 and notch1b signals
produced by TCDD result from a blockade of a process down-
stream in the Wnt signaling pathway needed for endothelial
cell localization and valve formation. If this were the case, feed-
back mechanisms might upregulate bmp4 and notch1b in an
attempt to restore normal Wnt signaling.
Blood Regurgitation, Valve Function, and Circulation
Because TCDD affects stroke volume and blood ﬂow
(Carney et al. 2006), it is possible that the effect on valve
formation is secondary to an emerging loss of contractility and
blood movement through the heart. The ﬂow of blood through
the heart is thought to generate signals that play an important
role in valve formation (Hove et al., 2003). Silent heart (sih)
mutants, with no blood ﬂow, exhibit no EC formation.
Similarly, cardiofunk mutants with no early blood ﬂow, have
defective valve cushion formation (Bartman et al., 2004;
Sehnert et al., 2002).
It is noteworthy however that although neither the silent
heart nor cardiofunk mutations alters the restricted bmp4
expression at the AV boundary, indicating that loss of blood
ﬂow does not alter AV boundary speciﬁcation (Bartman et al.,
2004). The effect of TCDD on localization of endothelial cells
and molecular markers at the AV boundary is far more similar
to the jekyll mutant, which produces delocalized bmp4 and
notch1b expression, pericardial edema, a loss of endothelial
cell localization at the AV boundary, and blood regurgitation
by 48 hpf (Walsh and Stainier, 2001). Thus, although TCDD
could produce altered valve development by altering blood
ﬂow, it is also possible that TCDD interferes with a develop-
mental process that is independent of blood ﬂow.
Environmental Factors and Valve Development
Over the past decade numerous studies have identiﬁed and
characterized zebraﬁsh mutants in an attempt to understand the
key genes needed for normal heart development and function
(Chen et al., 1996; Lee et al., 1994; Stainier et al., 1993, 1996).
Although these studies have been useful in identifying genetic
factors contributing to pathological conditions involving the
cardiovascular system, there is little doubt that environmental
causes also lead to heart abnormalities. By using the zebraﬁsh,
a well-established developmental model system, to study the
effects of TCDD on heart valve development, we can combine
our results with a wealth of knowledge obtained using genetic
methods. This is a step toward the long-term goal of under-
standing how environmental and genetic factors combine to
cause heart abnormalities and disease.
SUPPLEMENTARY DATA
Supplementary data are available online at http://toxsci.
oxfordjournals.org/.
FUNDING
National Institutes of Health grant (R01 ES012716), from the
National Institute of Environmental Health Sciences, to W.H.
and R.E.P.; the University of Wisconsin Sea Grant Institute;
National Sea Grant College Program; National Oceanic and
Atmospheric Administration; U.S. Department of Commerce
grant number (NA 16RG2257); and Sea Grant Project numbers
(R/BT-17, R/BT-20, and R/BT-22) to W.H. and R.E.P.
ACKNOWLEDGMENTS
We thank Chad Vezina, Dagmara Antkiewicz, Adrian Grimes,
Thomas Bartman, and Mary Halloran for useful discussions.
We thank Randall Peterson for providing the bmp4 and
notch1b plasmids, Beth Roman and Jau-Nian Chen for the
Tg(ﬂk1:GFP) line of zebraﬁsh and Jackie Holquist, Dorothy
Nesbit, C. Crows, and N. Jones for technical assistance. The
contents are solely the responsibility of the authors and do not
necessarily represent the ofﬁcial view of the National Institute
of Environmental Health Sciences, National Institutes of
Health.
REFERENCES
Antkiewicz, D. S., Burns, C. G., Carney, S. A., Peterson, R. E., and
Heideman, W. (2005). Heart malformation is an early response to TCDD in
embryonic zebraﬁsh. Toxicol. Sci. 84, 368–377.
Armstrong, E. J., and Bischoff, J. (2004). Heart valve development: Endothelial
cell signaling and differentiation. Circ. Res. 95, 459–470.
Bartman, T., Walsh, E. C., Wen, K. K., McKane, M., Ren, J., Alexander, J.,
Rubenstein, P. A., and Stainier, D. Y. (2004). Early myocardial function
affects endocardial cushion development in zebraﬁsh. PLoS Biol. 2, E129.
Beis, D., Bartman, T., Jin, S. W., Scott, I. C., D’Amico, L. A., Ober, E. A.,
Verkade, H., Frantsve, J., Field, H. A., Wehman, A., et al. (2005). Genetic
and cellular analyses of zebraﬁsh atrioventricular cushion and valve
development. Development 132, 4193–4204.
Belair, C. D., Peterson, R. E., and Heideman, W. (2001). Disruption of
erythropoiesis by dioxin in the zebraﬁsh. Dev. Dyn. 222, 581–594.
Bello, S. M., Heideman, W.,andPeterson, R.E.(2004). 2,3,7,8-Tetrachlorodibenzo-
p-dioxin inhibits regression of the common cardinal vein in developing
zebraﬁsh. Toxicol. Sci. 78, 258–266.
Carney, S. A., Chen, J., Burns, C. G., Xiong, K. M., Peterson, R. E., and
Heideman, W. (2006). Aryl hydrocarbon receptor activation produces heart-
310 MEHTA, PETERSON, AND HEIDEMANspeciﬁc transcriptional and toxic responses in developing zebraﬁsh. Mol.
Pharmacol. 70, 549–561.
Chen, J. N., Haffter, P., Odenthal, J., Vogelsang,E., Brand,M., van Eeden, F. J.,
Furutani-Seiki,M.,Granato,M.,Hammerschmidt,M.,Heisenberg,C.P.,etal.
(1996). Mutations affecting the cardiovascular system and other internal
organs in zebraﬁsh. Development 123, 293–302.
Cross, L. M., Cook, M. A., Lin, S., Chen, J. N., and Rubinstein, A. L. (2003).
Rapid analysis of angiogenesis drugs in a live ﬂuorescent zebraﬁsh assay.
Arterioscler. Thromb. Vasc. Biol. 23, 911–912.
Emmanouilides, G. C., Allen, H. D., Riemenschneider, T. A., and
Gutgesell, H. P. (1998). Clinical Synopsis of Moss and Adams’ Heart
Disease in Infants, Children, and Adolescents. Williams and Wilkins,
Baltimore, MD.
Enciso, J. M., Gratzinger, D., Camenisch, T. D., Canosa, S., Pinter, E., and
Madri, J. A. (2003). Elevated glucose inhibits VEGF-A-mediated endocar-
dial cushion formation: Modulation by PECAM-1 and MMP-2. J. Cell Biol.
160, 605–615.
Flanagan, T. C., and Pandit, A. (2003). Living artiﬁcial heart valve alternatives:
A review. Eur. Cell. Mater. 6, 28–45; discussion 45
Goldberg, S. J., Lebowitz, M. D., Graver, E. J., and Hicks, S. (1990). An
association of human congenital cardiac malformations and drinking water
contaminants. J. Am. Coll. Cardiol. 16, 155–164.
Grego-Bessa, J., Diez, J., Timmerman, L., and de la Pompa, J. L. (2004). Notch
and epithelial-mesenchyme transition in development and tumor progression:
Another turn of the screw. Cell Cycle 3, 718–721.
Grimes, A. C., Stadt, H. A., Shepherd, I. T., and Kirby, M. L. (2006). Solving
an enigma: Arterial pole development in the zebraﬁsh heart. Dev. Biol. 290,
265–276.
Heid, S. E., Walker, M. K., and Swanson, H. I. (2001). Correlation of
cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl
hydrocarbon receptor activation. Toxicol. Sci. 61, 187–196.
Henry, T. R., Spitsbergen, J. M., Hornung, M. W., Abnet, C. C., and
Peterson, R. E. (1997). Early life stage toxicity of 2,3,7,8-tetrachlorodibenzo-
p-dioxin in zebraﬁsh (Danio rerio). Toxicol. Appl. Pharmacol. 142, 56–68.
Hove, J. R., Koster, R. W., Forouhar, A. S., Acevedo-Bolton, G., Fraser, S. E.,
and Gharib, M. (2003). Intracardiac ﬂuid forces are an essential epigenetic
factor for embryonic cardiogenesis. Nature 421, 172–177.
Hu, N., Sedmera, D., Yost, H. J., and Clark, E. B. (2000). Structure and
function of the developing zebraﬁsh heart. Anat. Rec. 260, 148–157.
Hurlstone, A. F., Haramis, A. P., Wienholds, E., Begthel, H., Korving, J., Van
Eeden, F., Cuppen, E., Zivkovic, D., Plasterk, R. H., and Clevers, H. (2003).
The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature
425, 633–637.
Ivnitski, I., Elmaoued, R., and Walker, M. K. (2001). 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) inhibition of coronary development is preceded by
a decrease in myocyte proliferation and an increase in cardiac apoptosis.
Teratology 64, 201–212.
Ivnitski-Steele, I. D., and Walker, M. K. (2003). Vascular endothelial growth
factor rescues 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibition of coronary
vasculogenesis. Birth Defects Res. A Clin. Mol. Teratol. 67, 496–503.
Jiao, K., Kulessa, H., Tompkins, K., Zhou, Y., Batts, L., Baldwin, H. S., and
Hogan, B. L. (2003). An essential role of Bmp4 in the atrioventricular
septation of the mouse heart. Genes Dev. 17, 2362–2367.
Kuehl, K. S., and Loffredo, C. A. (2006). A cluster of hypoplastic left heart
malformation in Baltimore, Maryland. Pediatr. Cardiol. 27, 25–31.
Lee, R. K., Stainier, D. Y., Weinstein, B. M., and Fishman, M. C. (1994).
Cardiovascular development in the zebraﬁsh. II. Endocardial progenitors are
sequestered within the heart ﬁeld. Development 120, 3361–3366.
Milan, D. J., Giokas, A. C., Serluca, F. C., Peterson, R. T., and MacRae, C. A.
(2006). Notch1b and neuregulin are required for speciﬁcation of central
cardiac conduction tissue. Development 133, 1125–1132.
Rottbauer, W., Wessels, G., Dahme, T., Just, S., Trano, N., Hassel, D.,
Burns, C. G., Katus, H. A., and Fishman, M. C. (2006). Cardiac myosin light
chain-2: A novel essential component of thick-myoﬁlament assembly and
contractility of the heart. Circ. Res. 99, 323–331.
Scherz, P. J., Huisken, J., Sahai-Hernandez, P., and Stainier, D. Y. (2008).
High-speed imaging of developing heart valves reveals interplay of
morphogenesis and function. Development 135, 1179–1187.
Sehnert, A. J., Huq, A., Weinstein, B. M., Walker, C., Fishman, M., and
Stainier, D. Y. (2002). Cardiac troponin T is essential in sarcomere assembly
and cardiac contractility. Nat. Genet. 31, 106–110.
Stainier, D. Y., Beis, D., Jungblut, B., and Bartman, T. (2002). Endocardial
cushion formation in zebraﬁsh. Cold Spring Harb. Symp. Quant. Biol. 67,
49–56.
Stainier, D. Y., Fouquet, B., Chen, J. N., Warren, K. S., Weinstein, B. M.,
Meiler, S. E., Mohideen, M. A., Neuhauss, S. C., Solnica-Krezel, L.,
S c h i e r ,A .F . ,et al. (1996). Mutations affecting the formation and function
ofthecardiovascularsysteminthezebraﬁshembryo.Development123,285–292.
Stainier, D. Y., Lee, R. K., and Fishman, M. C. (1993). Cardiovascular
development in the zebraﬁsh. I. Myocardial fate map and heart tube
formation. Development 119, 31–40.
Thackaberry, E. A., Jiang, Z., Johnson, C. D., Ramos, K. S., and Walker, M. K.
(2005a). Toxicogenomic proﬁle of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the
murine fetal heart: Modulation of cell cycle and extracellular matrix genes.
Toxicol. Sci. 88, 231–241.
Thackaberry, E. A., Nunez, B. A., Ivnitski-Steele, I. D., Friggins, M., and
Walker, M. K. (2005b). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on
murine heart development: Alteration in fetal and postnatal cardiac growth,
and postnatal cardiac chronotropy. Toxicol. Sci. 88, 242–249.
Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T.,
Zheng, Z. J., Flegal, K., O’Donnell, C., Kittner, S., et al. (2006). Heart
disease and stroke statistics–2006 update: a report from the American Heart
Association Statistics Committee and Stroke Statistics Subcommittee.
Circulation. 113, e85–e151.
Timmerman, L. A., Grego-Bessa, J., Raya, A., Bertran, E., Perez-Pomares, J. M.,
Diez, J., Aranda, S., Palomo, S., McCormick, F., Izpisua-Belmonte, J. C., et al.
(2004). Notch promotes epithelial-mesenchymal transition during cardiac
development and oncogenic transformation. Genes Dev. 18, 99–115.
Vesely, I. (2005). Heart valve tissue engineering. Circ. Res. 97, 743–755.
Walsh, E. C., and Stainier, D. Y. (2001). UDP-glucose dehydrogenase
required for cardiac valve formation in zebraﬁsh. Science 293, 1670–1673.
Wang, W. D., Huang, C. J., Lu, Y. F., Hsin, J. P., Prabhakar, V. R.,
Cheng, C. F., and Hwang, S. P. (2006). Heart-targeted overexpression of
Nip3a in zebraﬁsh embryos causes abnormal heart development and cardiac
dysfunction. Biochem. Biophys. Res. Commun. 347, 979–987.
Yelon, D. (2001). Cardiac patterning and morphogenesis in zebraﬁsh. Dev.
Dyn. 222, 552–563.
TCDD CAUSES HEART VALVE DEFECTS IN ZEBRAFISH 311